TRUP — Trupanion, Inc.

Summary of Trupanion, Inc. Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Total Revenue: $376.9 million, up 12% year-over-year.
• Subscription Revenue: $261.4 million, up 15% year-over-year.
• Total Subscription Pets: Increased 5% year-over-year to over 1,096,000 pets.
• Adjusted Operating Income (AOI): $45 million, up 20% from Q4 2024, with a subscription AOI of $43.1 million (16.5% margin).
• Net Income: $5.6 million ($0.13 per share), compared to $1.7 million ($0.04 per share) in Q4 2024.
• Free Cash Flow: $25.3 million, up from $21.8 million year-over-year.
• Cash and Short-term Investments: $370.7 million, with total debt reduced to $111.8 million.

2. Strategic Updates and Business Highlights

• Record Year: 2025 marked a record year with over $900 million in revenue and $518 million in adjusted operating income.
• Retention Improvement: Trailing twelve-month retention improved consistently throughout the year, reaching an average of 98.34%.
• Pet Acquisition: Gross pet ads increased by 8% year-over-year, and subscription net pet growth was 50% in Q4.
• Investment in Marketing: Increased brand awareness efforts targeting pet parents, particularly through veterinary channels and direct-to-consumer strategies.
• New Product Initiatives: Plans to launch a lower-priced insurance offering and a pet food product (Landspath) aimed at enhancing pet health and retention.

3. Forward Guidance and Outlook

• 2026 Revenue Guidance: Expected to be between $1.55 billion and $1.58 billion, with subscription revenue projected to grow by approximately 14%.
• Adjusted Operating Income Guidance: Anticipated to be between $173 million and $187 million, representing 19% year-over-year growth.
• Q1 2026 Guidance: Total revenue expected in the range of $376 million to $382 million, with subscription revenue between $265 million and $268 million.

4. Bad News, Challenges, or Points of Concern

• Adverse Development: A slight adverse development of $900,000 impacted the loss ratio, which was 70.5% for the full year.
• Declining Other Revenue Segment: Revenue from non-subscription products is expected to decline as new enrollments cease for a major partner.
• Internal Rate of Return (IRR): Blended IRR decreased to 23% in Q4, down from 30% for the full year, raising concerns about investment efficiency.
• Veterinary Inflation: Ongoing monitoring of veterinary inflation, which remains a risk factor for future pricing and margins.

5. Notable Q&A Insights

• Brand Spend Success: Management highlighted successful brand spend initiatives that have improved conversion rates and pet acquisition.
• Retention Cohorts: Retention improvements were noted across all cohorts, particularly in those with lower rate increases, although first-year retention remains a challenge.
• Market Strategy for Lower-Priced Plans: Plans for a lower-priced insurance offering are in development, aiming to capture a broader market segment amidst tighter budgets for pet owners.
• Investment Focus: Management emphasized the importance of AOI as a measure of profitability and indicated a balanced approach to reinvesting in pet acquisition, technology, and debt reduction.

Overall, Trupanion demonstrated strong financial performance and growth in 2025, with strategic initiatives aimed at enhancing pet acquisition and retention. However, challenges such as declining revenue from non-subscription products and a decrease in IRR warrant attention as the company moves forward.